/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR
INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./
TSX-V: SVS
VANCOUVER, BC, Oct. 31,
2023 /CNW/ - Solarvest BioEnergy Inc. (TSXV:
SVS) ("Solarvest" or the "Company") wishes to
announce that Mr. Michael Farley has
been appointed as President of the Company effective immediately
following the resignation of Mr. Claes
Ellegaard who has agreed to tender his resignation.
Mr. Farley is an entrepreneur and corporate, business advisor to
health and wellness companies in international markets. Dr. Farley
was involved in dozens of financial, market entry and M&A
transactions since the early 2000s. He is also partnered with a
corporate advisory firm in Switzerland offering IR services to NA life
science small caps in Europe. In
the 1990s, Mr. Farley managed technology and investment programs at
the Canadian Foreign Affairs Department. He holds a PhD in the
Philosophy of Science from the Université de Montréal.
Solarvest is also pleased to announce that Mr. Garth Greenham has been appointed as COO of the
Company effective October 31,
2023.
Mr. Greenham is an executive of the Company and a corporate
director with an extensive record with both privately-held and
publicly-traded health care companies. He served as President of
the global aquaculture division of Novartis Inc. He started his
career with Johnson & Johnson (J&J) where he served 15
years mostly with McNeil Pharmaceutical in numerous management
positions in Operations and Contract & Export Sales. He joined
Cobequid Life Sciences Inc.(KQR) and served as Director of Sales,
Marketing & Operations for nine years and helped grow the
company to global leader in the field of aquaculture animal
vaccines.
The Company would like to thank Mr. Claes Ellegaard for his tenure during
challenging times for the Company.
About Solarvest
Solarvest BioEnergy Inc. is an algae biologics company whose
production platform provides it with an extremely flexible system
capable of producing numerous products from Omega 3 fatty acids to
human therapeutic proteins.
Forward-Looking
Statements
This news release contains forward-looking statements, which
relate to future events or future performance and reflect
management's current expectations and assumptions. Such
forward-looking statements reflect management's current beliefs and
are based on assumptions made by and information currently
available to the Company. Investors are cautioned that these
forward-looking statements are neither promises nor guarantees, and
are subject to risks and uncertainties that may cause future
results to differ materially from those expected. These
forward-looking statements are made as of the date hereof and,
except as required under applicable securities legislation, the
Company does not assume any obligation to update or revise them to
reflect new events or circumstances.
Neither the TSX-V nor its regulation services provider (as
that term is defined in the policies of the
TSX-V) accepts responsibility for the
adequacy or accuracy of this press release.
SOURCE Solarvest BioEnergy Inc.
